Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

APOA5 antibody (N-Term)

APOA5 Reactivity: Human WB, IHC (p) Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN543847
  • Target See all APOA5 Antibodies
    APOA5 (Apolipoprotein A-V (APOA5))
    Binding Specificity
    • 9
    • 7
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivity
    • 52
    • 10
    • 7
    • 2
    • 1
    • 1
    Human
    Host
    • 42
    • 18
    • 1
    Rabbit
    Clonality
    • 44
    • 18
    Polyclonal
    Conjugate
    • 39
    • 7
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This APOA5 antibody is un-conjugated
    Application
    • 42
    • 23
    • 23
    • 12
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purpose
    Rabbit polyclonal antibody raised against synthetic peptide of APOA5.
    Cross-Reactivity
    Human
    Immunogen
    A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human APOA5.
    Top Product
    Discover our top product APOA5 Primary Antibody
  • Application Notes
    Western Blot (1:1000)
    Immunohistochemistry (1:10-50)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Hubacek, Wang, Skodová, Adámková, Vráblík, Horínek, Stulc, Ceska, Talmud: "APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels." in: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 46, Issue 6, pp. 773-7, (2008) (PubMed).

    Dorfmeister, Zeng, Dichlberger, Nilsson, Schaap, Hubacek, Merkel, Cooper, Lookene, Putt, Whittall, Lee, Lins, Delsaux, Nierman, Kuivenhoven, Kastelein, Vrablik, Olivecrona, Schneider, Heeren et al.: "Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. ..." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 10, pp. 1866-71, (2008) (PubMed).

    Luo, Kranzler, Zuo, Wang, Blumberg, Gelernter: "CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study." in: Human molecular genetics, Vol. 14, Issue 16, pp. 2421-34, (2005) (PubMed).

  • Target
    APOA5 (Apolipoprotein A-V (APOA5))
    Alternative Name
    Apolipoprotein A V (ApoA V) (APOA5 Products)
    Synonyms
    APOAV antibody, RAP3 antibody, 1300007O05Rik antibody, Apoav antibody, apo-AV antibody, apoA-V antibody, APOA5 antibody, MGC140487 antibody, rap3 antibody, apoav antibody, apoa-v antibody, apolipoprotein A5 antibody, apolipoprotein A-V antibody, apolipoprotein A5 L homeolog antibody, APOA5 antibody, Apoa5 antibody, apoa5.L antibody, apoa5 antibody
    Gene ID
    116519
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
You are here:
Support